Clinical Trial

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

Name: Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients — clinical trial record (NCT07342803)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a multicenter, randomized, masked, active and placebo controlled, Phase II clinical study to evaluate the efficacy, safety, and pharmacokinetics of LP-003 injection in adult patients with moderate to severe persistent allergic asthma.

Trial Details

NCT Number	NCT07342803
Lead Sponsor	Longbio Pharma
Conditions	Allergic Asthma
Enrollment	200 participants
Start Date	2025-01-25
Primary Completion	2027-12-28 (estimated)
Study Completion	2029-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-15